MedscapeIn Immunotherapy, Approved Biomarkers Pose Many ProblemsMedscapeThe US Food and Drug Administration (FDA) recently licensed for the first time use of an immunotherapy solely on the basis of the presence of a biomarker. The labeling was approved… Continue reading
Gene therapy reverses muscular dystrophy in dogs in world firstBioNewsResearchers from France and the UK have demonstrated the safety and efficacy of a gene therapy that could treat Duchenne muscular dystrophy (DMD). The gene therapy significantly incr… Continue reading
|
Stem Cell Therapy can provide a surgery-free solution to knee and shoulder issues
Colorado Springs Gazette There was a time when stem cell therapy was out of reach for most people, but it has become increasingly accessible in recent years; and a go-to solution for a range of physiological complications. “Stem cells are blank cells in the body that can … |
Medgadget (blog) |
Global Stem Cell Market – Positive long term growth outlook 2016-21
Medgadget (blog) According to the report “Global Stem Cell Market,” published by Market Data Forecast, the global market is projected to reach USD 30.19 billion by 2021 from USD 15.82 billion in 2016, at a CAGR of 13.8% from 2016 to 2021. Stem cell therapy, also known … US Regenerative Medicine Market to Grow at a CAGR of 23.53% to 2021satPRnews (press release) |
|
Kite Files the Industry’s First CAR–T Marketing Authorization Application in Europe for Axicabtagene Ciloleucel
Business Wire (press release) This application represents the first chimeric antigen receptor (CAR) T-cell therapy submitted to the EMA. Axicabtagene ciloleucel is currently under review by the U.S. Food and Drug Administration (FDA), and the FDA has set a Prescription Drug User … |